Skip to content

Doopang Transcutaneous Electrical Nerve Stimulator

by Ybrain Inc.

510(k) K232749

Active European Union and United States

CE MDD 510(k)

Valid until

No date given

CE: no date in EUDAMED. FDA: not time-limited

FDA recalls

None found

in data synced 6 Oct 2026

Documents

None linked in EUDAMED

A group certificate may exist

Trust

Unverified

Source EUDAMED, FDA 510(k), synced 6 Oct 2026.

Regulatory status

as of registry sync 6 Oct 2026

RegionAuthorizationNumberDateStatus
United StatesFDA 510(k)SESE 510(k) Substantially Equivalent · Traditional NumberK232749 Date11 Jun 2024ClearedStatusActive
European UnionCE/MDD EUDAMED Number— Date—StatusActive

Official records

From the FDA record

Received by the FDA
8 Sep 2023
FDA decision
11 Jun 2024 (Substantially Equivalent)
FDA review time
277 days from receipt to decision
Public document
510(k) summary on file with the FDA

From the FDA 510(k) record K232749 (openFDA), as read on 6 Oct 2026. Quoted as published, gaps included; nothing on this list is generated.

Across registries

2 registries list this device

  • FDA 510(k) K232749 decided 11 Jun 2024 Active
  • EUDAMED Active

Coverage

2 jurisdictions

United States of AmericaSwedenFinlandLatviaEstoniaDenmarkLithuaniaIrelandNetherlandsGermanyPolandFranceBelgiumLuxembourgCzech RepublicSlovakiaAustriaHungaryRomaniaSloveniaBulgariaPortugalSpainItalyCroatiaGreeceMaltaCyprus
  • Active
  • Expiring
  • Withdrawn
  • Listed
  • Not covered
  • European Union CE/MDD Active
  • United States FDA 510(k) Active

Specification

EUDAMED · 510(k)

Full name
Doopang
510(k) Number
FDA product code
PCC
FDA applicant
Ybrain, Inc.
Device class
Class II
Regulation
21 CFR Part 882.5891
Advisory committee
Neurology
FDA decision
SESE Substantially Equivalent

Overview

AI-generated summary, 18 Sep 2026

Written by a language model from registry data. Not verified by deviCERTS or the manufacturer. The registry data above is the record.

The Doopang is a transcutaneous electrical nerve stimulator classified as a nerve stimulator for migraine relief. It employs TENS technology to deliver controlled electrical impulses to the trigeminal nerve, targeting pain signal transmission associated with migraine episodes. This device is designed to provide non-invasive, medication-free migraine management by modulating nerve activity.

The Doopang is supplied as a portable, single-use or reusable device (as per regulatory context) and is intended for home or clinical use. It operates under FDA 510(k) clearance (K232749) and MDD authorization, adhering to Class II medical device standards. The device requires no special storage conditions and is intended for adult migraine sufferers seeking alternative pain relief methods. No MRI safety data is specified.

Devices cleared under K232749

1 device · FDA GUDID

Devices that FDA's GUDID lists as cleared or approved under this submission number. One submission usually covers a whole product family, so the sizes and models are listed here once.

Devices cleared under K232749
UDI-DISize and differences
DOOPANG YPS-301BD
Ybrain Inc.
YPS-301BD08800020403032 —On the market

Similar devices

Other devices filed under FDA product code PCC (Stimulator, Nerve, Electrical, Transcutaneous, For Migraine).

Other devices from Ybrain Inc.